Transparency Market Research Report Added "Intravenous Immunoglobulin Market" to its database.

Albany, NY -- (SBWire) -- 03/22/2016 --A new market research report by Transparency Market Research, titled "Intravenous Immunoglobulin (IVIG) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", provides an extensive review of the market for intravenous immunoglobulin and evaluates the growth potential of the market in addition to providing its key areas of focus.

The report provides an extensive evaluation of the factors fuelling and impeding the growth of the market for IVIG. The projections in the study are collated by evaluating the present market trends as well as the market's potential in the forecast horizon from 2013 to 2019 on the basis of both value and volume. The study also comprises a comprehensive evaluation of each geographical segment, thus helping in determining the prevalent opportunities within these regions. The key government regulations related to the use of IVIG purification and production have also been discussed in depth. SWOT evaluation of the prime market players is also provided to illustrate the business strategies adopted by these key players.

As per the report, the market for IVIG is experiencing exponential growth owing to the increasing healthcare expenditure, the rising geriatric population, and the soaring count of patients having bleeding disorders. In addition, factors such as the rising count of patients suffering from asthma, autoimmune diseases, and other pathological conditions are also impacting the market positively.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1930

Furthermore, the launch of new advanced therapies and a number of technological advancements taking place for the treatment of various diseases will further augment the market for intravenous immunoglobulin, as per this study. On the other hand, the increasing side effects related to IVIG usage, including acute kidney failure, dermatitis, and venous thrombosis, may inhibit the growth of the market in the coming years. In addition, the soaring costs involved in the treatment of diseases and strict regulatory restraints may also impede the growth of the market in forthcoming years, as per this study.

On the basis of geography, the report segments the market into Asia Pacific, North America, Europe, and Rest of the World (RoW). Amongst these, North America led the market for intravenous immunoglobulin in 2013 due to the rising count of people suffering from asthma, autoimmune diseases, and other diseases. Europe trailed North America and constituted the second largest share in the market due to the rising geriatric population base in the region. On the other hand, according to the report, the Asia Pacific intravenous immunoglobulin market will also experience exponential growth in the coming years owing to the rising health awareness amongst people in this region.

As stated in the report, the chief players dominant in the market are Bharat Serums and Vaccines Ltd., Baxter International Inc., Biotest AG,CSL Limited, Octapharma AG, Grifols S.A., Kedrion S.p.A, and OMRIX Biopharmaceuticals Ltd., among others.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/